tr 987
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Nov 1, 2016 (NCT03154619)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tr 987
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06707090 | Phase 3 | Nov 30, 2024 | Turning Point Therapeutics |
| NCT06707103 | Phase 3 | Nov 30, 2024 | Turning Point Therapeutics |
| NCT03154619 | Phase 2 | Nov 1, 2016 | SerenaGroup, Inc., Turning Point Therapeutics |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Turning Point Therapeutics | For profit | 3 | 2 | 2 | 2016 |
| SerenaGroup, Inc. | For profit | 1 | 1 | 1 | 2016 |
2 organizations
Page 1 / 1